Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Histopathology|October 22, 2011
Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomyBianca A M H van Veggel, Inge M van Oort, J Alfred Witjes, et al.
Therapeutic Advances in Medical Oncology|December 17, 2024
Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysisCatharina J P Op 't Hoog, Sabien J E Bosman, Emmy Boerrigter, et al.
Cancers|August 12, 2023
Reliability and Efficiency of the CAPRI-3 Metastatic Prostate Cancer Registry Driven by Artificial IntelligenceDianne Bosch, Malou C P Kuppen, Metin Tascilar, et al.
The Prostate|July 22, 2014
KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatmentSiebren Dijkstra, Gisele H J M Leyten, Sander A Jannink, et al.
Histopathology|May 13, 2010
The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomyInge M van Oort, H Maxim Bruins, Lambertus A L M Kiemeney, et al.
Clinical Nuclear Medicine|November 23, 2017
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily PracticeMaarten J van der Doelen, Malou C P Kuppen, Marianne A Jonker, et al.
Clinical Genitourinary Cancer|May 11, 2013
Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the NetherlandsMichel D Wissing, Inge M van Oort, Winald R Gerritsen, et al.
EJNMMI Reports|November 26, 2024
[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]FluciclovineCato C Loeff, Willemijn van Gemert, Bastiaan M Privé, et al.
Radiology|April 20, 2011
Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancerThomas Hambrock, Diederik M Somford, Henkjan J Huisman, et al.
Therapeutic Drug Monitoring|February 9, 2018
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate CancerGuillemette E Benoist, Eric van der Meulen, Inge M van Oort, et al.
Pageof 14